Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
about
Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner.Comparative genomic analysis of a multiple antimicrobial resistant enterotoxigenic E. coli O157 lineage from Australian pigs.Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract.Antibacterial and Antioxidant Activities of Essential Oils from Artemisia herba-alba Asso., Pelargonium capitatum × radens and Laurus nobilis L.Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics.Shiga toxin-producing Escherichia coli in human, cattle, and foods. Strategies for detection and control.
P2860
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@ast
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@en
type
label
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@ast
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@en
prefLabel
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@ast
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@en
P2093
P2860
P356
P1476
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
@en
P2093
Elias A Rahal
Farah J Nassar
Ghassan M Matar
Natalie Kazzi
P2860
P356
10.3389/FCIMB.2012.00138
P577
2012-11-15T00:00:00Z